Gender and chronic obstructive pulmonary disease

Why it matters

MeiLan K. Han, Dirkje Postma, David M. Mannino, Nicholas D. Giardino, A (Sonia) Buist, Jeffrey L. Curtis, Fernando J. Martinez

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

The prevalence of chronic obstructive pulmonary disease (COPD) in women is increasing, as is hospitalization for COPD. The number of women dying of COPD in the United States now surpasses men. Despite this, research suggests that physicians are still more likely to correctly diagnose men with COPD than women. Increased tobacco use in women likely explains some of the increase in the prevalence of COPD in women, but data suggest that women may actually be at greater risk of smoking-induced lung function impairment, more severe dyspnea, and poorer health status for the same level of tobacco exposure. The degree to which these observations represent biologic, physiologic, or sociologic differences is not known. Nonsmokers with COPD are also more likely to be female. In addition, new evidence is emerging that men and women may be phenotypically different in their response to tobacco smoke, with men being more prone to an emphysematous phenotype and women an airway predominant phenotype. Inasmuch as COPD is a disease of inflammation, it is also possible that sexual dimorphism of the human immune response may also be responsible for gender differences in the disease. More data are still needed on what the implications of these findings are on therapy. In this clinical commentary, we present current knowledge regarding how gender influences the epidemiology, diagnosis, and presentation of COPD in addition to physiologic and psychologic impairments and we attempt to offer insight into why these differences might exist and how this may influence therapeutic management.

Original languageEnglish (US)
Pages (from-to)1179-1184
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume176
Issue number12
DOIs
StatePublished - Dec 15 2007

Fingerprint

Chronic Obstructive Pulmonary Disease
Tobacco
Phenotype
Tobacco Use
Smoke
Sex Characteristics
Dyspnea
Health Status
Epidemiology
Hospitalization
Smoking
Inflammation
Physicians
Lung
Therapeutics
Research

Keywords

  • Obstructive lung disease
  • Sex
  • Smoking
  • Tobacco susceptibility

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Han, M. K., Postma, D., Mannino, D. M., Giardino, N. D., Buist, A. S., Curtis, J. L., & Martinez, F. J. (2007). Gender and chronic obstructive pulmonary disease: Why it matters. American Journal of Respiratory and Critical Care Medicine, 176(12), 1179-1184. https://doi.org/10.1164/rccm.200704-553CC

Gender and chronic obstructive pulmonary disease : Why it matters. / Han, MeiLan K.; Postma, Dirkje; Mannino, David M.; Giardino, Nicholas D.; Buist, A (Sonia); Curtis, Jeffrey L.; Martinez, Fernando J.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 176, No. 12, 15.12.2007, p. 1179-1184.

Research output: Contribution to journalArticle

Han, MK, Postma, D, Mannino, DM, Giardino, ND, Buist, AS, Curtis, JL & Martinez, FJ 2007, 'Gender and chronic obstructive pulmonary disease: Why it matters', American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 12, pp. 1179-1184. https://doi.org/10.1164/rccm.200704-553CC
Han, MeiLan K. ; Postma, Dirkje ; Mannino, David M. ; Giardino, Nicholas D. ; Buist, A (Sonia) ; Curtis, Jeffrey L. ; Martinez, Fernando J. / Gender and chronic obstructive pulmonary disease : Why it matters. In: American Journal of Respiratory and Critical Care Medicine. 2007 ; Vol. 176, No. 12. pp. 1179-1184.
@article{f84adcd8b2044cfeafb88323a9e40aac,
title = "Gender and chronic obstructive pulmonary disease: Why it matters",
abstract = "The prevalence of chronic obstructive pulmonary disease (COPD) in women is increasing, as is hospitalization for COPD. The number of women dying of COPD in the United States now surpasses men. Despite this, research suggests that physicians are still more likely to correctly diagnose men with COPD than women. Increased tobacco use in women likely explains some of the increase in the prevalence of COPD in women, but data suggest that women may actually be at greater risk of smoking-induced lung function impairment, more severe dyspnea, and poorer health status for the same level of tobacco exposure. The degree to which these observations represent biologic, physiologic, or sociologic differences is not known. Nonsmokers with COPD are also more likely to be female. In addition, new evidence is emerging that men and women may be phenotypically different in their response to tobacco smoke, with men being more prone to an emphysematous phenotype and women an airway predominant phenotype. Inasmuch as COPD is a disease of inflammation, it is also possible that sexual dimorphism of the human immune response may also be responsible for gender differences in the disease. More data are still needed on what the implications of these findings are on therapy. In this clinical commentary, we present current knowledge regarding how gender influences the epidemiology, diagnosis, and presentation of COPD in addition to physiologic and psychologic impairments and we attempt to offer insight into why these differences might exist and how this may influence therapeutic management.",
keywords = "Obstructive lung disease, Sex, Smoking, Tobacco susceptibility",
author = "Han, {MeiLan K.} and Dirkje Postma and Mannino, {David M.} and Giardino, {Nicholas D.} and Buist, {A (Sonia)} and Curtis, {Jeffrey L.} and Martinez, {Fernando J.}",
year = "2007",
month = "12",
day = "15",
doi = "10.1164/rccm.200704-553CC",
language = "English (US)",
volume = "176",
pages = "1179--1184",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "12",

}

TY - JOUR

T1 - Gender and chronic obstructive pulmonary disease

T2 - Why it matters

AU - Han, MeiLan K.

AU - Postma, Dirkje

AU - Mannino, David M.

AU - Giardino, Nicholas D.

AU - Buist, A (Sonia)

AU - Curtis, Jeffrey L.

AU - Martinez, Fernando J.

PY - 2007/12/15

Y1 - 2007/12/15

N2 - The prevalence of chronic obstructive pulmonary disease (COPD) in women is increasing, as is hospitalization for COPD. The number of women dying of COPD in the United States now surpasses men. Despite this, research suggests that physicians are still more likely to correctly diagnose men with COPD than women. Increased tobacco use in women likely explains some of the increase in the prevalence of COPD in women, but data suggest that women may actually be at greater risk of smoking-induced lung function impairment, more severe dyspnea, and poorer health status for the same level of tobacco exposure. The degree to which these observations represent biologic, physiologic, or sociologic differences is not known. Nonsmokers with COPD are also more likely to be female. In addition, new evidence is emerging that men and women may be phenotypically different in their response to tobacco smoke, with men being more prone to an emphysematous phenotype and women an airway predominant phenotype. Inasmuch as COPD is a disease of inflammation, it is also possible that sexual dimorphism of the human immune response may also be responsible for gender differences in the disease. More data are still needed on what the implications of these findings are on therapy. In this clinical commentary, we present current knowledge regarding how gender influences the epidemiology, diagnosis, and presentation of COPD in addition to physiologic and psychologic impairments and we attempt to offer insight into why these differences might exist and how this may influence therapeutic management.

AB - The prevalence of chronic obstructive pulmonary disease (COPD) in women is increasing, as is hospitalization for COPD. The number of women dying of COPD in the United States now surpasses men. Despite this, research suggests that physicians are still more likely to correctly diagnose men with COPD than women. Increased tobacco use in women likely explains some of the increase in the prevalence of COPD in women, but data suggest that women may actually be at greater risk of smoking-induced lung function impairment, more severe dyspnea, and poorer health status for the same level of tobacco exposure. The degree to which these observations represent biologic, physiologic, or sociologic differences is not known. Nonsmokers with COPD are also more likely to be female. In addition, new evidence is emerging that men and women may be phenotypically different in their response to tobacco smoke, with men being more prone to an emphysematous phenotype and women an airway predominant phenotype. Inasmuch as COPD is a disease of inflammation, it is also possible that sexual dimorphism of the human immune response may also be responsible for gender differences in the disease. More data are still needed on what the implications of these findings are on therapy. In this clinical commentary, we present current knowledge regarding how gender influences the epidemiology, diagnosis, and presentation of COPD in addition to physiologic and psychologic impairments and we attempt to offer insight into why these differences might exist and how this may influence therapeutic management.

KW - Obstructive lung disease

KW - Sex

KW - Smoking

KW - Tobacco susceptibility

UR - http://www.scopus.com/inward/record.url?scp=37149022825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149022825&partnerID=8YFLogxK

U2 - 10.1164/rccm.200704-553CC

DO - 10.1164/rccm.200704-553CC

M3 - Article

VL - 176

SP - 1179

EP - 1184

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 12

ER -